MedPath

The effectiveness of Vonoprazan for delayed bleeding after ESD in antithrombotic drug-users: a prospective study.

Not Applicable
Conditions
early gastric cancer, gastric adenoma
Registration Number
JPRN-UMIN000029300
Lead Sponsor
kurashiki central hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1)perforation during ESD 2)allergy for vonoprazan

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the rate of delayed bleeding after ESD
Secondary Outcome Measures
NameTimeMethod
the rate of thromboembolism, bleeding event which are not assosiated with ESD(cerebral hemorrhage, gastrointestinal bleeding), the need for blood transfusion,the days of hospitalization, mortality
© Copyright 2025. All Rights Reserved by MedPath